Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
-
Field
-
the Section for Plant Biochemistry, Department of Plant and Environmental Plant Sciences, Faculty of SCIENCE, University of Copenhagen. We are located in Frederiskberg, Copenhagen. Principal supervisor
-
from Aarhus University and University of Copenhagen, as well as international partners. Field experiments, digital technologies -- including modelling and remote sensing, as well as interactions with
-
located at Aalborg University, campus Copenhagen, but some traveling is expected. You may read more about the department here: https://www.create.aau.dk/om-create You may obtain further information from
-
, University of Copenhagen. We offer creative and stimulating working conditions in dynamic and international research environment. Terms of employment The average weekly working hours are 37 hours per week. The
-
with the University of Copenhagen. Disseminating your research findings in highly ranked peer-reviewed journals and international conference proceedings. Strengthening our international collaboration
-
faculties at NTNU, University of Oslo / Oslo University Hospital and University of Copenhagen and cover competences from basic molecular microbiology, chemical synthesis and structural biology/modelling
-
Hospital and University of Copenhagen and cover competences from basic molecular microbiology, chemical synthesis and structural biology/modelling, bioinformatics, cell biology and immunology/infectious
-
services. Conduct system demonstrations in real-world neural network applications such as natural language processing tasks with our collaborators in the University of Copenhagen. Disseminating your research
-
with SODAS at the University of Copenhagen. PhD scholarship in Linearized floating wind farm modelling - DTU Wind Denmark Posted on 04/29/2024 Are you a curious, self-driven individual with a strong
-
), The Novo Nordisk Foundation Center for Stem Cell Medicine (renew) at University of Copenhagen, and Bioneer A/S that aims at developing new in vitro disease models and cell therapies using human induced